Ivabradine for the Therapy of Chronic Stable Angina Pectoris: a Systematic Review and Meta-Analysis

BACKGROUND AND OBJECTIVES: Coronary artery disease (CAD) is the number one cause of death worldwide. The I(f) channel inhibitor ivabradine serves as second line medication for the CAD leading symptom angina pectoris. This systematic review and meta-analysis assess the existing evidence of ivabradine...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalvelage, Christina, Stoppe, Christian, Marx, Nikolaus, Marx, Gernot, Benstoem, Carina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Cardiology 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440996/
https://www.ncbi.nlm.nih.gov/pubmed/32725985
http://dx.doi.org/10.4070/kcj.2020.0031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440996/
https://www.ncbi.nlm.nih.gov/pubmed/32725985
http://dx.doi.org/10.4070/kcj.2020.0031

Ejemplares similares